Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

Explore BCIQ profiles by entering a company name.

Projenx Inc.

Name: Projenx Inc. - BioCentury Company Profiles - BCIQ
Creator: Biocentury

Headquarters: Nissequogue, NY, United States of America

Year Founded: 2022

Status: Private

BioCentury | Feb 27, 2025

Guest Commentary

The next rare disease roadblock: American innovation moving ex-U.S.

As regulatory hurdles push early-stage trials out of the U.S., three things FDA can do to bring them back

BioCentury | Jan 6, 2023

Emerging Company Profile

A snapshot of gene therapy and CAR T innovation, the emergence of protein stabilization, and new thinking in neurology

BioCentury | Dec 24, 2022

BioCentury Commentary

BioCentury’s analysts look back at a year when industry took some slings and arrows but delivered breakthroughs, and predict what’ll be hot in 2023

BioCentury | Nov 2, 2022

Emerging Company Profile

Project ALS and Medical Excellence-backed company hopes to take same regulatory path forged by Amylyx

BioCentury | Aug 24, 2022

Finance

Fund is led by John Prufeta and three Domain Associates alums

BioCentury | May 19, 2022

Management Tracks

Plus SOBI’s Batten joins Veru, and updates from FlandersBio, Google Health, Morphic and more

Items per page:

1 - 6 of 6